REVENUE MEMORANDUM CIRCULAR NO. 110-2022 issued on July 21, 2022 publishes the full text of the May 30, 2022 letter from Food and Drug Administration OICDirector General Oscar G. Gutierrez, Jr. endorsing updates to the “List of VAT-Exempt Medicines” under Republic Act No. 11534 (CREATE Act), which now includes certain medicines prescribed for cancer and COVID-19 treatment.
            Also, as clarified under Q&A No. 1 of Revenue Memorandum Circular No. 99-2021, the effectivity of the VAT exemption of the covered medicines and medical devices under the CREATE Act shall take effect on the date of publication by the FDA of the said updates to the said list.